Completed NA INTERVENTIONAL 2-arm NCT03058718

Procalcitonin-Guided Antibiotic Therapy in Bronchiectasis

Effectiveness of Procalcitonin-Guided Antibiotic Therapy in Acute Exacerbations of Bronchiectasis: a Randomized Controlled Trial

Sponsor: Qilu Hospital of Shandong University

Conditions Antibiotic Therapy Bronchiectasis Procalcitonin

Interventions Clinical Experience Procalcitonin

Updated 5 times since 2017 Last updated: Feb 16, 2017 Started: Jan 1, 2014 Primary completion: Jul 1, 2016 Completion: Feb 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03058718, this NA trial focuses on Antibiotic Therapy and Bronchiectasis and remains completed. Sponsored by Qilu Hospital of Shandong University, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2017 — Jan 2021 [monthly]

Completed NA
May 2017 — Jun 2017 [monthly]

Completed NA

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Qilu Hospital of Shandong University

Data source: Qilu Hospital of Shandong University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.